NCT04015050 (WAVE) is a NA clinical trial of milk based infant formula in Healthy Term Infants, sponsored by Nutricia Research.

Who is sponsoring NCT04015050?

NCT04015050 is sponsored by Nutricia Research.

What drugs are being tested in NCT04015050?

Interventions in NCT04015050: milk based infant formula.

What condition does NCT04015050 study?

NCT04015050 studies Healthy Term Infants.

Is NCT04015050 still recruiting?

NCT04015050 is currently completed. Last updated 17 December 2021.

Last reviewed 2021-12-17 · How we verify

NCT04015050: WAVE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.

Completed NA Last updated 17 December 2021

What this trial tests

NA trial testing milk based infant formula in Healthy Term Infants in 279 participants. Completed in 3 December 2021.

Timeline

10 July 2019

Primary endpoint
3 December 2021

3 December 2021

Quick facts

Lead sponsor	Nutricia Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	279
Start date	10 July 2019
Primary completion	3 December 2021
Estimated completion	3 December 2021
Sites	1 location across Poland

Drugs / interventions tested

milk based infant formula

Conditions studied

Healthy Term Infants — all drugs for Healthy Term Infants →

Sponsor

Nutricia Research — full company profile →

Who can join

Adults 0 Days to 17 Weeks, any sex, with Healthy Term Infants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomised, controlled, double-blind, parallel group, multi-country study to investigate the safety and tolerance of infant formula with prebiotics and postbiotics in healthy term infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Nutricia Research trials

Trials by the same sponsor.

NCT07243743 — Assessment of the Glycemic Responses to Nutritional Products-INQ-2526 · NA · completed
NCT06797349 — Glin4: Assessment of the Glycemic Responses to Nutritional Products · Phase 4 · completed
NCT06920550 — A Growth Artificial Intelligence Algorithm for leNgth and Weight Study · recruiting
NCT06628024 — Determination of the Postprandial Amino Acid Uptake Kinetics of Yoghurt Vs Milk. · NA · completed
NCT05731206 — Hypoallergenicity of a Hydrolyzed Protein Infant Formula · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04015050 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nutricia Research
Last refreshed: 17 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04015050.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing